Developing high-affinity, oxygen-insensitive [NiFe]-hydrogenases as biocatalysts for energy conversion
Biochemical Society Transactions · 2023
DOI: 10.1042/bst20230120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2023. Verfasst von Chris Greening und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Nickel, Hydrogenase. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
The splitting of hydrogen (H2) is an energy-yielding process, which is important for both biological systems and as a means of providing green energy. In biology, this reaction is mediated by enzymes called hydrogenases, which utilise complex nickel and iron cofactors to split H2 and transfer the resulting electrons to an electron-acceptor. These [NiFe]-hydrogenases have received considerable attention as catalysts in fuel cells, which utilise H2 to produce electrical current. [NiFe]-hydrogenases are a promising alternative to the platinum-based catalysts that currently predominate in fuel cells due to the abundance of nickel and iron, and the resistance of some family members to inhibition by gases, including carbon monoxide, which rapidly poison platinum-based catalysts. However, the majority of characterised [NiFe]-hydrogenases are inhibited by oxygen (O2), limiting their activity and stability. We recently reported the isolation and characterisation of the [NiFe]-hydrogenase Huc from Mycobacterium smegmatis, which is insensitive to inhibition by O2 and has an extremely high affinity, making it capable of oxidising H2 in air to below atmospheric concentrations. These properties make Huc a promising candidate for the development of enzyme-based fuel cells (EBFCs), which utilise H2 at low concentrations and in impure gas mixtures. In this review, we aim to provide context for the use of Huc for this purpose by discussing the advantages of [NiFe]-hydrogenases as catalysts and their deployment in fuel cells. We also address the challenges associated with using [NiFe]-hydrogenases for this purpose, and how these might be overcome to develop EBFCs that can be deployed at scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
- Securing Antarctica's Environmental Future, Monash University, Clayton, VIC 3800, Australia.
- Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia.
- ARC Research Hub for Carbon Utilisation and Recycling, Monash University, Clayton, VIC 3800, Australia.
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, Oxford OX1 3QR, U.K.
- Centre for Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia.
ORCID-Profile: Chris Greening, Rhys Grinter
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Greening, C., Kropp, A., Vincent, K., & Grinter, R. (2023). Developing high-affinity, oxygen-insensitive [NiFe]-hydrogenases as biocatalysts for energy conversion. Biochemical Society Transactions. https://doi.org/10.1042/bst20230120
Vancouver
Greening C, Kropp A, Vincent K, Grinter R. Developing high-affinity, oxygen-insensitive [NiFe]-hydrogenases as biocatalysts for energy conversion. Biochemical Society Transactions. 2023. doi:10.1042/bst20230120
BibTeX
@article{Greening2023,
author = {Greening, Chris and Kropp, Ashleigh and Vincent, Kylie and Grinter, Rhys},
title = {Developing high-affinity, oxygen-insensitive [NiFe]-hydrogenases as biocatalysts for energy conversion},
journal = {Biochemical Society Transactions},
year = {2023},
doi = {10.1042/bst20230120}
}
EUVIMED